Biotron Limited (ASX:BIT)
0.0030
0.00 (0.00%)
Sep 25, 2025, 9:59 AM AEST
Biotron Revenue
In the fiscal year ending June 30, 2025, Biotron had annual revenue of 1.81M AUD with 10.24% growth. Biotron had revenue of -868.00 in the half year ending June 30, 2025.
Revenue
1.81M
Revenue Growth
+10.24%
P/S Ratio
2.56
Revenue / Employee
604.54K
Employees
3
Market Cap
4.65M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 1.81M | 168.51K | 10.24% |
Jun 30, 2024 | 1.65M | 213.83K | 14.94% |
Jun 30, 2023 | 1.43M | -127.24K | -8.16% |
Jun 30, 2022 | 1.56M | 96.58K | 6.61% |
Jun 30, 2021 | 1.46M | 658.92K | 82.05% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.79B |
Telix Pharmaceuticals | 1.01B |
Ansell | 3.06B |
Mesoblast | 26.23M |